Roberts SK - Search Results

1

Impact of a Mediterranean diet on hepatic and metabolic outcomes in non-alcoholic fatty liver disease: The MEDINA randomised controlled trial.

George ES, Reddy A, Nicoll AJ, Ryan MC, Itsiopoulos C, Abbott G, Johnson NA, Sood S, Roberts SK, Tierney AC. George ES, et al. Among authors: roberts sk. Liver Int. 2022 Jun;42(6):1308-1322. doi: 10.1111/liv.15264. Epub 2022 Apr 26. Liver Int. 2022. PMID: 35357066 Free PMC article. Clinical Trial.

2

Urotensin II: a novel vasoactive mediator linked to chronic liver disease and portal hypertension.

Kemp W, Krum H, Colman J, Bailey M, Yandle T, Richards M, Roberts S. Kemp W, et al. Liver Int. 2007 Nov;27(9):1232-9. doi: 10.1111/j.1478-3231.2007.01539.x. Liver Int. 2007. PMID: 17919235

3

Norfloxacin treatment for clinically significant portal hypertension: results of a randomised double-blind placebo-controlled crossover trial.

Kemp W, Colman J, Thompson K, Madan A, Vincent M, Chin-Dusting J, Kompa A, Krum H, Roberts S. Kemp W, et al. Liver Int. 2009 Mar;29(3):427-33. doi: 10.1111/j.1478-3231.2008.01850.x. Epub 2008 Jul 29. Liver Int. 2009. PMID: 18673434 Clinical Trial.

4

Epidemiology of hepatitis B-associated hepatocellular carcinoma in Victoria.

Sinclair M, Roberts S, Kemp W, Knight V, Dev A, Gow P, Philpott H, Kronborg I, Arachchi NJ, Bell S, Lim L, Gorelik A, Nicoll A; Melbourne Collaboration for Study of Hepatocellular Carcinoma. Sinclair M, et al. Intern Med J. 2013 May;43(5):501-6. doi: 10.1111/imj.12068. Intern Med J. 2013. PMID: 23279328

5

Novel population-based study finding higher than reported hepatocellular carcinoma incidence suggests an updated approach is needed.

Hong TP, Gow P, Fink M, Dev A, Roberts S, Nicoll A, Lubel J, Kronborg I, Arachchi N, Ryan M, Kemp W, Knight V, Farrugia H, Thursfield V, Desmond P, Thompson AJ, Bell S. Hong TP, et al. Hepatology. 2016 Apr;63(4):1205-12. doi: 10.1002/hep.28267. Epub 2016 Feb 19. Hepatology. 2016. PMID: 26435297

6

Sorafenib in the treatment of hepatocellular carcinoma: a multi-centre real-world study.

Doyle A, Marsh P, Gill R, Rodov M, Mohsen W, Varma P, Hong T, Strasser SI, Bell S, Ryan M, Nicoll A, Lubel J, Gow PJ, Fink MA, Roberts S, Kemp W, Kronborg I, Arachchi N, Knight V, Dev A. Doyle A, et al. Scand J Gastroenterol. 2016 Aug;51(8):979-85. doi: 10.3109/00365521.2016.1166518. Epub 2016 May 10. Scand J Gastroenterol. 2016. PMID: 27161568

7

Five-year efficacy and safety of tenofovir-based salvage therapy for patients with chronic hepatitis B who previously failed LAM/ADV therapy.

Lim L, Thompson A, Patterson S, George J, Strasser S, Lee A, Sievert W, Nicoll A, Desmond P, Roberts S, Marion K, Bowden S, Locarnini S, Angus P. Lim L, et al. Liver Int. 2017 Jun;37(6):827-835. doi: 10.1111/liv.13331. Epub 2016 Dec 22. Liver Int. 2017. PMID: 27896895

8

Impact of viral hepatitis aetiology on survival outcomes in hepatocellular carcinoma: A large multicentre cohort study.

Mgaieth S, Kemp W, Gow P, Fink M, Lubel J, Nicoll A, Gazzola A, Hong T, Ryan M, Knight V, Dev AT, Sood S, Bell S, Paul E, Roberts SK. Mgaieth S, et al. Among authors: roberts sk. J Viral Hepat. 2017 Nov;24(11):982-989. doi: 10.1111/jvh.12717. Epub 2017 Jun 9. J Viral Hepat. 2017. PMID: 28414893

9

Systematic review and meta-analysis: non-invasive detection of non-alcoholic fatty liver disease related fibrosis in the obese.

Ooi GJ, Mgaieth S, Eslick GD, Burton PR, Kemp WW, Roberts SK, Brown WA. Ooi GJ, et al. Among authors: roberts sk. Obes Rev. 2018 Feb;19(2):281-294. doi: 10.1111/obr.12628. Epub 2017 Nov 9. Obes Rev. 2018. PMID: 29119725

10

Beneficial response to mycophenolate mofetil by patients with autoimmune hepatitis who have failed standard therapy, is predicted by older age and lower immunoglobulin G and INR levels.

Nicoll AJ, Roberts SK, Lim R, Mitchell J, Weltman M, George J, Wigg A, Stuart K, Gow P, MacQuillan G, Tse E, Levy M, Sood S, Zekry A, Cheng W, Mitchell J, Skoien R, Sievert W, Strasser SI, McCaughan GW; ALA Clinical Research Network, Gastroenterological Society of Australia. Nicoll AJ, et al. Among authors: roberts sk. Aliment Pharmacol Ther. 2019 May;49(10):1314-1322. doi: 10.1111/apt.15248. Epub 2019 Apr 11. Aliment Pharmacol Ther. 2019. PMID: 30972807

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

285 results

Search Page